Unique ID issued by UMIN | UMIN000053387 |
---|---|
Receipt number | R000060931 |
Scientific Title | A randomized, single-blind, placebo-controlled, crossover study on the suppressive effects of viscosity-adjusted enteral formula on blood glucose level |
Date of disclosure of the study information | 2024/01/25 |
Last modified on | 2024/01/18 14:08:14 |
Suppressive effects of a test food on blood glucose level
Suppressive effects of a test food on blood glucose level
A randomized, single-blind, placebo-controlled, crossover study on the suppressive effects of viscosity-adjusted enteral formula on blood glucose level
Suppressive effects of a test food on blood glucose level
Japan |
Patients receiving enteral tube feeding
Not applicable |
Others
NO
To evaluate the effects of viscosity-adjusted enteral formula on blood glucose level
Efficacy
Area under the curve of postprandial blood glucose
Blood glucose, insulin level, blood amino acids, GLP-1 level, and GIP level
Interventional
Cross-over
Randomized
Individual
Single blind -participants are blinded
Placebo
2
Treatment
Food |
Single ingestion of placebo food, washout period for 2 weeks, single ingestion of test food.
Single ingestion of test food, washout period for 2 weeks, single ingestion of placebo food.
50 | years-old | <= |
65 | years-old | > |
Male and Female
Subjects aged 50 or more and less than 65.
1)Subjects who meet both of the following criteria in the preliminary survey.
i)Fasting blood glucose level is 126 mg/dL or more.
ii)HbA1c value is 6.5 % or more.
2)Subjects who have been diagnosed with diabetes.
3)Subjects taking medications that may affect blood glucose levels.
4)Subjects who are under medical treatment of diseases in liver, kidneys, heart, lungs, digestive system, blood, endocrine and metabolic systems, or who have serious medical history of those diseases.
5)Subjects who exhibit allergic symptoms due to intake of milk or soybean-derived ingredients.
6)Subjects who donated/collected blood components or 200 mL or more of blood in the past 1 month, or who donated/collected 400 mL or more of blood on the past 4 months.
7)Subjects who plan to participate in other clinical trials during the trial period.
8)Others who are judged by the investigator to be inappropriate as participants in this test.
20
1st name | Mamoru |
Middle name | |
Last name | Oki |
Seishukai Clinic
urology
111-0036
3-18-5 Matsugaya, Taito-ku, Tokyo, Japan
03-5827-0930
t-takahama@seishukai.or.jp
1st name | Hirofumi |
Middle name | |
Last name | Sonoki |
Morinaga Milk Industry Co., LTD.
Health Care & Nutritional Science Institute, R&D Division
252-8583
1-83, 5-Chome, Higashihara, Zama-city, Kanagawa Pref. Japan
046-252-3057
h-sonoki@morinagamilk.co.jp
Seishukai Clinic
Morinaga Milk Industry Co., Ltd.
Profit organization
Japan Conference of Clinical Research
1-13-23 Minami-ikebukuro, Toshima-ku, Tokyo, Japan
03-6868-7022
jccr-info@jccr.jp
NO
医療法人社団 成守会 成守会クリニック/Seishukai Clinic
2024 | Year | 01 | Month | 25 | Day |
Unpublished
Preinitiation
2023 | Year | 11 | Month | 13 | Day |
2023 | Year | 12 | Month | 21 | Day |
2024 | Year | 01 | Month | 26 | Day |
2024 | Year | 04 | Month | 04 | Day |
2024 | Year | 01 | Month | 18 | Day |
2024 | Year | 01 | Month | 18 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000060931
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |